Fennec Pharmaceuticals, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 35.35% vs 120.00% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 42.11% vs -4.11% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13.40",
          "val2": "9.90",
          "chgp": "35.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.80",
          "val2": "-6.90",
          "chgp": "44.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "1.50",
          "chgp": "-46.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.40",
          "val2": "-7.60",
          "chgp": "42.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-283.10%",
          "val2": "-693.90%",
          "chgp": "41.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 126.83% vs 1,335.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 97.24% vs 29.77% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "65.10",
          "val2": "28.70",
          "chgp": "126.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.50",
          "val2": "-17.20",
          "chgp": "120.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.70",
          "val2": "5.00",
          "chgp": "14.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "-21.70",
          "chgp": "97.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "54.00%",
          "val2": "-600.90%",
          "chgp": "65.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

13.40

9.90

35.35%

Operating Profit (PBDIT) excl Other Income

-3.80

-6.90

44.93%

Interest

0.80

1.50

-46.67%

Exceptional Items

-0.00

0.00

Consolidate Net Profit

-4.40

-7.60

42.11%

Operating Profit Margin (Excl OI)

-283.10%

-693.90%

41.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 35.35% vs 120.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 42.11% vs -4.11% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

65.10

28.70

126.83%

Operating Profit (PBDIT) excl Other Income

3.50

-17.20

120.35%

Interest

5.70

5.00

14.00%

Exceptional Items

-0.10

-0.10

Consolidate Net Profit

-0.60

-21.70

97.24%

Operating Profit Margin (Excl OI)

54.00%

-600.90%

65.49%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 126.83% vs 1,335.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 97.24% vs 29.77% in Dec 2023

All Annual Results